SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001787306-22-000023
Filing Date
2022-04-19
Accepted
2022-04-19 16:12:24
Documents
8
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2022arcutisbiotherapeutic.htm DEF 14A 904970
2 chart-27a588cb271349cd963.jpg GRAPHIC 42013
3 chart-4ba16f9678bc4b1ea10.jpg GRAPHIC 59730
4 chart-c4ab39d6ec704e538b1.jpg GRAPHIC 43913
5 image.jpg GRAPHIC 22983
6 image1.jpg GRAPHIC 22360
7 sampleproxycard1.jpg GRAPHIC 94280
8 sampleproxycard2.jpg GRAPHIC 95133
  Complete submission text file 0001787306-22-000023.txt   1430745
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39186 | Film No.: 22835075
SIC: 2834 Pharmaceutical Preparations